Pioneer(R) Surgical Technology Receives 510(k) Clearance To Market FortrOss(TM), A Next Generation Bone Void Filler

Pioneer Surgical Technology, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market FortrOss, a novel bone graft substitute utilizing the power of nanotechnology for orthopaedic applications. The FortrOss bone void filler is a scaffold for the in-growth of new bone and other connective tissues, when superior bone regeneration is required.

More: continued here

Filed under: Bones on September 8th, 2008